Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer - BeOne

Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer

BeOne Study ID

BGB-290-302

ClinicalTrials.gov ID

NCT03519230

China Drug Trials ID

CTR20171666

Study Overview

Sex: Female

Age: 18 Years / N/A

No Study Documents

Study Overview

Sex: Female

Age: 18 Years / N/A

No Study Documents